Analysts who follow Anika Therapeutics Inc (ANIK) on average expect it to fall -8.03% over the next twelve months. Those same analysts give the stock an average rating of Buy.
That average rating earns Anika Therapeutics Inc an Analyst Ranking of 34, which means it ranks higher than 34 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating ANIK a Buy today. Find out what this means to you and get the rest of the rankings on ANIK!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Anika Therapeutics Inc Stock Today?
Anika Therapeutics Inc (ANIK) stock is trading at $30.99 as of 2:05 PM on Wednesday, Nov 30, a rise of $1.53, or 5.19% from the previous closing price of $29.46. The stock has traded between $29.54 and $30.99 so far today. Volume today is below average. So far 31,908 shares have traded compared to average volume of 93,909 shares.
Click Here to get the full Stock Report for Anika Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
